Sirolimus (CAS 53123-88-9) — formula C51H79NO13, molecular weight 914.2; category organic chemicals.
Documented applications: Uses: Triene macrolide antibiotic derived from Streptomyces hygroscopicus, Used in immunochemistry research and as a therapeutic immunosuppressant and antirestenotic (blocks reoccurrence of stenosis), [Merck Index], Tool for immunochemistry., Medication: Immunosuppressant, Used to prevent rejection in organ transplantation, it is especially useful in kidney transplants. [Wikipedia], Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients, Methods of Manufacturing: Triene macrolide antibiotic isolated from Streptomyces hygroscopicus., Formulations, Preparations: Rapamune, Rapamycin, Oral: Solution 1mg, mL Rapamune (Wyeth). Tablets: 1 mg Rapamune (with povidone), (Wyeth), 2 mg Rapamune (with Povidone), (Wyeth)., General Manufacturing Information: Information available in 2004 indicated that Sirolimus was used in the manufacture of pharmaceutical preparations in the following countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Mexico, New Zealand, Norway, Poland, Romania, Singapore, Spain, Sweden, Switzerland, Thailand, United Kingdom, USA (1, 2).
Sirolimus is a carbon-based organic compound with CAS registry number 53123-88-9 and molecular formula C51H79NO13 (molecular weight 914.2), belonging to the organic chemicals segment of chemical raw materials.
CAS number: 53123-88-9
Its molecular formula C51H79NO13 comprises 51 C, 79 H, 1 N, 13 O atoms.
Also known as: Sirolimus · Rapamycin
Category: organic chemicals
The CAS registry number of Sirolimus is 53123-88-9.
Molecular formula C51H79NO13, molecular weight 914.2.
It is also registered under: Sirolimus, Rapamycin.
Recorded applications: Uses: Triene macrolide antibiotic derived from Streptomyces hygroscopicus, Used in immunochemistry research and as a therapeutic immunosuppressant and antirestenotic (blocks reoccurrence of stenosis), [Merck Index], Tool for immunochemistry., Medication: Immunosuppressant, Used to prevent rejection in organ transplantation, it is especially useful in kidney transplants. [Wikipedia], Use Classification: Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients, Methods of Manufacturing: Triene macrolide antibiotic isolated from Streptomyces hygroscopicus., Formulations, Preparations: Rapamune, Rapamycin, Oral: Solution 1mg, mL Rapamune (Wyeth). Tablets: 1 mg Rapamune (with povidone), (Wyeth), 2 mg Rapamune (with Povidone), (Wyeth)., General Manufacturing Information: Information available in 2004 indicated that Sirolimus was used in the manufacture of pharmaceutical preparations in the following countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Mexico, New Zealand, Norway, Poland, Romania, Singapore, Spain, Sweden, Switzerland, Thailand, United Kingdom, USA (1, 2).
Category: Organic Chemicals.
Public-database records for Sirolimus (CAS 53123-88-9), reproduced here for independent cross-checking.
| GHS notification summary | 4.7% (2 / 43) |
|---|---|
| Reported hazard statements | H341 (11.6%), H351 (79.1%), H361 (81.4%), H372 (81.4%) |
This chemical does not meet GHS hazard criteria for 4.7% (2 of 43) of reports.
H341 (11.6%): Suspected of causing genetic defects [Warning Germ cell mutagenicity]
| GHS notification summary | 4.7% (2 / 43) |
|---|
| 沸点 | 183-185 |
|---|---|
| 熔点 | 183-185 °C |
| 溶解度 | 1.73e-03 g/L |
| LogP | 4.63 |
| LogP | 4.3 |
| CAS Registry Number | 53123-88-9 |
|---|---|
| PubChem CID | 5284616 |
| 分子式 | C51H79NO13 |
| IUPAC 名称 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone |
| UNII（FDA） | W36ZG6FT64 |
rapamycin; Sirolimus; (-)-Rapamycin; 53123-88-9; Rapamune; rapalimus; AY-22989; WY-090217; FYARRO; HYFTOR; sirolimusum; Npc-12g; Antibiotic AY 22989; RAPA; Rapammune; SILA 9268A
| 分子量 | 914.2 |
|---|---|
| XLogP3 | 6 |
| 氢键供体数 | 3 |
| 氢键受体数 | 13 |
| 可旋转键数 | 6 |
| 精确质量 | 913.55514157 |
| 单同位素质量 | 913.55514157 |
| 拓扑极性表面积 | 195 |
| 重原子数 | 65 |
| 形式电荷 | 0 |
Sirolimus · CAS 53123-88-9 · C51H79NO13. UNII W36ZG6FT64. 沸点: 183-185; 熔点: 183-185 °C; 溶解度: 1.73e-03 g/L.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd. · Reply within one business day.